Novavax expands Sanofi license for Matrix-M adjuvant use
Go back to Novavax expands Sanofi license for Matrix-M adjuvant use| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.03 +0.47 (5.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.56 | 52 Week High | $9.23 | |||
| Open | $8.54 | 52 Week Low | $1.16 | |||
| Day High | $9.09 | P/E | N/A | |||
| Day Low | $8.45 | EPS | $-0.30 | |||
| Volume | 3,553,419 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 44.11 +0.54 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.57 | 52 Week High | $44.76 | |||
| Open | $43.90 | 52 Week Low | $36.81 | |||
| Day High | $44.55 | P/E | N/A | |||
| Day Low | $43.86 | EPS | $0.00 | |||
| Volume | 3,106,957 | |||||
